Response Rates and Tolerance for mFOLFIRINOX Regimen in Indian Patients with Metastatic and Unresectable Gall Bladder Cancer - A Prospective Observational Study (Phase II)

Category Primary study
JournalHPB
Year 2023
This article has no abstract
Epistemonikos ID: 087f50aaaae7cf30f6d9fe0b58308472f3691483
First added on: Feb 16, 2025